Saturday, 20 April 2024

AMR


One of the major health issues facing the whole world today is Antimicrobial Resistance (AMR). And this alone is not the health crisis of today's generation, because it is not handled on time, it will be the biggest health crisis for the next generation too. Experts in the field have already hoisted a red flag on the critical situation of a world without antibiological if necessary steps are not taken immediately. Even though AMR emerges naturally over time, blind use of antibiotics is one of the major reasons for AMR emerging. The hard fact is that antibiotic abuse and overuse is at risk of decades of medical advancements. It has often been found that over-the-counter availability cases of these lifesaving drugs makes worse as people buy antibiotic medicines for virus-causing diseases instead of bacteria. When antibiotics are so readily available, it's not necessary to take the necessary care. Another fact that AMR burden falls inequality on low and moderate income countries, where healthcare systems are overloaded and resources have increased. The seriousness of the situation that some reports can be estimated that India is likely to cause nearly 2 million deaths from AMR by 2050 as the country has the highest rate of antibiological immunity in bacteria generally causing infection. And the health facilities.

Naturally, the global community has declared AMR as a public health crisis and regulators around the world, along with Indian regulators, have already started measures to solve this problem at the war level as regulators seize this critical situation. Recently, the National Medical Commission has decided to create a general module on AMR control which will improve awareness and understanding of AMR among pregraduate, postgraduate medical students and teaching professionals in medical colleges. This is an appropriate step because there are some atrocious prescriptions from some doctors that write more antibiologically and unnecessarily. Commission's action in this regard is part of efforts to implement the National Action Scheme (NAP) on AMR which aims to reduce the spread of AMR in the country. Recently, the All India Chemist and Distributors Federation, an association of drug distributors and retailers across the country, has given an instruction to the government that the period or expiration date of use is required on the land of treatment use. Doctors prescription to stop the spread of AMR due to their overuse. The fact is that most often, people use old prescription for similar symptoms as previous diseases and take medications the doctor prescribed five years ago or six years ago. Doctors write the same antibiological at a specific time for a specific disease, but they still use the same prescription when the patient has the same disease after five years or six years. Undoubtedly, the medicine used by the patient five years ago may not be affected by his current disease. While the situation gets serious, experts have appealed drug regulators to play a vital role in countering the threat, as the main reason is misuse, overuse and less use of antibiotics. Regulators should literally implement a schedule H and H1 of drugs and cosmetics to stop OTC sales of antibiotics. Regulators shouldn't feel short in making sure pharmacists and hospitals are following the laws and selling schedule H and H1 drugs only on qualified doctors prescription. Delivering without pharmacists and selling without prescription should be stopped immediately to cover the risk of AMR. Government should pay attention to all these instructions and act fast as AMR is a ticking time bomb.
https://chat.whatsapp.com/ESnQA4VD8aRL8I87NxhJ73 

#QualityAssuranceToPatients - #QRCodeWhy not create a #QRCode on Medicine label to get Batch Quality Report?It would also prevent Black-Sheep Cos selling untested or failed batches.#Everyone

#QualityAssuranceToPatients - #QRCode

Why not create a #QRCode on Medicine label to get Batch Quality Report?

It would also prevent Black-Sheep Cos selling untested or failed batches.

#Everyone

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector . Therefore requirement of a new course like Pharm D / Pharma D (PB), which will produce professionals called Pharmacist and Pharmacotherapist. 

Thursday, 22 February 2024

So many regulatory bodies and governing bodies in pharmacy education: whims of my mind

PCI(Pharmacy Council Of India) and AICTE(All India Council for technical education) are the governing bodies in the pharmacy education , keeping in mind the compounding and dispensing as well as the technical aspects involved in Pharmaceutical Engineering .

Now with the advent of Pharm D course in pharmacy, which is clinically oriented 6 years course in pharmacy and the syllabus is designed such as  first 3 years are same as B.Pharm ( compounding and dispensing oriented) and next 2 years are same as MD Pharmacology (medically and clinically oriented) and 1 year of internship in an attached (minimum- 300 beded) hospital , one may expect MCI (medical council of India) to get into the thick of the things/matters.

As it requires an affiliation with a  hospital( minimum 300 beded), to get approval for an pharmaceutical institute from PCI to conduct the course , one must expect MCI(medical council of India) also to get involved as a regulatory and governing body.

PCI governs courses like : D.Pharm
                                         B.Pharm
                                        Pharm D and Pharm D(PB)

AICTE governs courses like : B.Pharm( jointly with PCI)
                                              M.Pharm

Now one must expect AICTE,PCI and MCI may jointly govern : Pharm D and Pharm D(PB)

But no, its not a rational thinking on my part. MCI will get involve only when the course is a medical one or may be when the professional doctor is dealing with a body part.
So, its fair enough that MCI is not involved into these matters.

                                             

Sunday, 11 February 2024

PHARMACIST IN HEALTHCARE/PHARMACARE

PHARMACIST IN HEALTHCARE.

Unless Indian healthcare service and infrastructure is made inclusive of pharmacy and pharmacists service, there is no scope for pharmacist in healthcare

Tuesday, 6 February 2024

High-Risk Drugs

High-Risk Drugs

"High risk medicines are those medicines that have a high risk of causing significant patient harm or death when used in error.- Google search

Although errors may or may not be more common than with other medicines, the consequences of errors with these medicines can be more devastating" - Google search.

"A – Antimicrobials

P – Potassium and other electrolytes, psychotropic medications

I – Insulin

N – Narcotics, opioids and sedatives

C – Chemotherapeutic agents

H – Heparin and other anticoagulants

S – Safer systems (e.g. safe administration of liquid medications using oral syringes)

Methods to reduce error include strategies such as:

👉 improving access to information about these drugs
👉 limiting access to high risk medications
👉 using Tallman* lettering to differentiate high risk medications
using auxiliary labels and automated alerts
👉 standardising the prescription, storage, preparation, and administration of these products."
------------
*Tallman lettering:
1.acetaZOLAMIDE vs. acetoHEXAMIDE.

2. buPROPion vs. busPIRone.

3.chlorproMAZINE vs. chlorproPAMIDE.

5.clomiPHENE vs. clomiPRAMINE.

6. cycloSERINE vs. cycloSPORINE."
- Google search.

Pharmacists should recollect their lessons on Routes of Administration, Times of Administration, LASA drug names and Importance of Administration by Medical attendant or under Medical supervision.

Identifying and self regulating them by Retail Pharmacists looks highly imminent Now in Public Interest.

Attn. #Pharmacists &
          #DrugsInspectors